Literature DB >> 7195503

Primary systemic carnitine deficiency. II. Renal handling of carnitine.

A G Engel, C J Rebouche, D M Wilson, A M Glasgow, C A Romshe, R P Cruse.   

Abstract

Renal tubular reabsorption rates, reabsorptive maxima, and apparent renal plasma excretory thresholds for carnitine were determined in four children with primary systemic carnitine deficiency (SCD), in two of the mothers of these children, in one patient with muscle carnitine deficiency (MCD), and in seven controls. In SCD the observed values were well below those found in six of seven controls, but one control, a healthy 20-year-old woman with normal muscle carnitine level, also exhibited a renal carnitine leak. In the two mothers of patients with SCD and in the case of MCD some of the parameters of the renal handling of carnitine were slightly altered. Tubular secretion of short-chain acylcarnitines was noted in patients and controls at high plasma free carnitine levels. Augmented excretion of short-chain acylcarnitines occurred at lower plasma free carnitine levels in the patients with SCD than in the other subjects. Free and short-chain acyl-carnitines may compete for the same renal reabsorptive site. A renal defect cannot fully account for primary SCD but may contribute to the carnitine depletion in this disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195503     DOI: 10.1212/wnl.31.7.819

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency.

Authors:  C A Stanley; F Sunaryo; D E Hale; J P Bonnefont; F Demaugre; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  Mitochondrial myopathies.

Authors:  S DiMauro; E Bonilla; M Zeviani; S Servidei; D C DeVivo; E A Schon
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Carnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementation.

Authors:  J Rasmussen; J A Thomsen; J H Olesen; T M Lund; M Mohr; J Clementsen; O W Nielsen; A M Lund
Journal:  JIMD Rep       Date:  2015-02-10

4.  Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.

Authors:  A Marzo; E Arrigoni Martelli; R Urso; M Rocchetti; V Rizza; J G Kelly
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.

Authors:  C J Rebouche; A G Engel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  C G Costa; L Dorland; I T de Almeida; C Jakobs; M Duran; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

7.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.

Authors:  J G Kelly; S Hunt; G D Doyle; M S Laher; M Carmody; A Marzo; E Arrigoni Martelli
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 9.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

10.  Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency.

Authors:  C J Rebouche; A G Engel
Journal:  In Vitro       Date:  1982-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.